Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,914 | 34,097 | 32,397 | 12,589 | 36,830 |
| Marketable Securities | 169,346 | 73,525 | 50,574 | 107,921 | N/A |
| Other current assets | 2,133 | 867 | 955 | 1,311 | 241 |
| TOTAL | $191,656 | $109,428 | $87,547 | $122,616 | $37,957 |
| Non-Current Assets | |||||
| PPE Net | 178 | 157 | 216 | 170 | 53 |
| Other Non-Current Assets | 1,605 | 1,315 | 1,640 | 229 | 465 |
| TOTAL | $1,783 | $1,472 | $1,856 | $399 | $518 |
| Total Assets | $193,439 | $110,900 | $89,403 | $123,015 | $38,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 7,000 | 5,833 |
| Accounts payable and accrued liabilities | 3,911 | 3,414 | 1,809 | 2,857 | 2,849 |
| Accrued Expenses | 5,531 | 6,810 | 3,709 | 3,518 | 3,808 |
| Other current liabilities | N/A | N/A | N/A | N/A | 114 |
| TOTAL | $9,749 | $10,509 | $5,824 | $13,400 | $12,724 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,151 | 8,652 |
| Other Non-Current Liabilities | 446 | 747 | 1,001 | 5 | 24 |
| TOTAL | $446 | $747 | $1,032 | $2,156 | $8,676 |
| Total Liabilities | $10,195 | $11,256 | $6,856 | $15,556 | $21,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,397 | 96,682 | 68,960 | 60,045 | 30,806 |
| Common Shares | 128 | 94 | 68 | 60 | 29 |
| Retained earnings | -329,804 | -287,045 | -239,134 | -210,069 | -180,917 |
| Other shareholders' equity | 148 | 61 | -29 | -122 | 0 |
| TOTAL | $183,244 | $99,644 | $82,547 | $107,459 | $17,075 |
| Total Liabilities And Equity | $193,439 | $110,900 | $89,403 | $123,015 | $38,475 |